Results 141 to 150 of about 166,627 (157)

Combination of Microneedles and MF59 Adjuvant as a Simple Approach to Enhance Transcutaneous Immunization

Journal of Biomedical Nanotechnology, 2020
Congcong Zhu
exaly  

The mechanism of action of MF59 – An innately attractive adjuvant formulation

Vaccine, 2012
D T O’Hagan
exaly  

MF59 adjuvant: the best insurance against influenza strain diversity

Expert Review of Vaccines, 2011
Rino Rappuoli, Derek O'hagan, Theodore F Tsai   +2 more
exaly  

The history of MF59® adjuvant: a phoenix that arose from the ashes

Expert Review of Vaccines, 2013
Rino Rappuoli, Derek O'hagan, Gary van Nest   +2 more
exaly  

MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1 tumor immunity in mice

International Immunopharmacology, 2012
Ming Yang, Min Wan, Mingli Fang
exaly  

Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59® adjuvant

Human Vaccines and Immunotherapeutics, 2012
Geert Leroux-Roels, Frédéric Clement, Uwe Nicolay   +2 more
exaly  

Safety of MF59™ adjuvant

Vaccine, 2008
Andreas Wack, Deborah Novicki, Viola Schultze   +2 more
exaly  

MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine

Human Vaccines and Immunotherapeutics, 2012
Mariagrazia Pizza, Manmohan Singh, Barbara C Baudner   +2 more
exaly  

The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect

Vaccine, 2013
Sylvie Bertholet, Alessandro Muzzi, Anja Seubert   +2 more
exaly  

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

Open Forum Infectious Diseases, 2014
Paul Spearman, Brenda M Y Leung, Patricia L Winokur   +2 more
exaly